• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢曲松在妇产科领域的基础研究]

[Fundamental study of ceftriaxone in the field of obstetrics and gynecology].

作者信息

Itoh K, Kondoh H, Hayasaki M, Noda K

出版信息

Jpn J Antibiot. 1984 Dec;37(12):2343-8.

PMID:6098727
Abstract

Excretion of ceftriaxone (Ro 13-9904, CTRX) into female genital organs was studied by determining its concentration in the dead space exudate of the patients who received radical hysterectomy due to uterocervical cancer. Data analysis was performed by the three-compartment model. The serum peak level of CTRX in the cubital vein was 177.74 micrograms/ml 1 hour after the initiation of intravenous drip infusion for 1 hour with 1 g. The concentration of CTRX in the exudate of pelvic dead space reached a peak of 62.75 micrograms/ml 4.61 hours after the start of administration and still showed a very high level of 25 micrograms/ml at 24 hours. The AUC of the excretion into the exudate of pelvic dead space was 1,432.43 micrograms X hr/ml. These results indicate that CTRX is a clinically useful drug, being excreted into the exudate of pelvic dead space favorably.

摘要

通过测定因子宫颈癌接受根治性子宫切除术患者死腔渗出液中的浓度,研究了头孢曲松(Ro 13 - 9904,CTRX)在女性生殖器官中的排泄情况。采用三室模型进行数据分析。以1g静脉滴注1小时后,肘静脉中CTRX的血清峰值水平在给药1小时后为177.74微克/毫升。给药开始4.61小时后,盆腔死腔渗出液中CTRX的浓度达到峰值62.75微克/毫升,24小时时仍显示出25微克/毫升的非常高的水平。盆腔死腔渗出液排泄的AUC为1432.43微克·小时/毫升。这些结果表明CTRX是一种临床有用的药物,能很好地排泄到盆腔死腔渗出液中。

相似文献

1
[Fundamental study of ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础研究]
Jpn J Antibiot. 1984 Dec;37(12):2343-8.
2
[Study on tissue transfer of ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的组织转移研究]
Jpn J Antibiot. 1984 Dec;37(12):2320-7.
3
[Basic and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2377-83.
4
[Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2406-15.
5
[Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床研究]
Jpn J Antibiot. 1984 Dec;37(12):2328-37.
6
[Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2364-70.
7
[Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的药代动力学及临床研究
Jpn J Antibiot. 1984 Dec;37(12):2304-19.
8
[Pharmacokinetic studies on ceftazidime in the obstetrical and gynecological field].[头孢他啶在妇产科领域的药代动力学研究]
Jpn J Antibiot. 1984 Jan;37(1):18-22.
9
[Fundamental and clinical study of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2384-90.
10
[Experimental and clinical evaluation on ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的实验与临床评估
Jpn J Antibiot. 1984 Dec;37(12):2298-303.